Pfizer involved in NIH scandal
A House Energy & Commerce Committee investigation finds that the National Institute for Mental Health Geriatric Psychiatry Branch Chief Trey Sunderland improperly shared spinal fluid and plasma samples with Pfizer. He received $285,000 for consulting work related to the samples. However, the committee finds "no evidence that Pfizer had any knowledge relating to the questionable conduct of Dr. Sunderland in connection with the [relevant Material Transfer Agreement] and the subsequent shipments of samples"...
You may also be interested in...
The HHS Office of Inspector General will focus its conflict-of-interest enforcement efforts on the National Institutes of Health in 2007, causing it to postpone pending studies of FDA
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.